Saturday - September 19, 2026
ICER to Develop Special Report on Prostate Cancer Treatment Darolutamide for CMS Public Comment
September 12, 2026
BOSTON, Massachusetts, Sept. 12 (TNSrpt) -- The Institute for Clinical and Economic Review issued the following news release:

* * *

ICER to Develop Special Report on Prostate Cancer Treatment Darolutamide for CMS Public Comment

-- Report will be submitted as public comment for Medicare Drug Price Negotiation Program --

-

BOSTON, September 10, 2026 - The Institute for Clinical and Economic Review (ICER) announced today that it will . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products